Submitted:
09 September 2025
Posted:
10 September 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
Mouse Breeding and Genotyping
Assessment of Embryonic Lethality in Constitutive Atxn2l-KO Mice
Immunohistochemistry
Imaging
Locomotor Phenotyping
Tamoxifen Preparation and Treatment
Global Proteomics
Proteome Interrogation for Pathway Enrichments
Statistics and Graphical Presentation
3. Results
Generation of Conditional KO Mice via Floxing Exons 10-17 in the Atxn2l Gene
Crossbreeding with Constitutive Cre-Deleters Confirms Embryonic Lethality of Homozygous ATXN2L-Null Mice
Crossbreeding with CamK2a-Dependent Cre/ERT2 Mice and Subsequent Tamoxifen Injection Generates Atxn2l-cKO in Adult Frontal Cortex Tissue
Atxn2l-cKO in Frontal Cortex Tissue Showed Mosaic Expression in CamK2a-Positive Neurons
CamK2a-Dependent Atxn2l-cKO Triggers Deficits of Spontaneous Horizontal Locomotion
CamK2a-Dependent Atxn2l-cKO Mouse Frontal Cortex Proteomics Shows ATXN2L Protein Reduction to 75% and Dysregulation of Alternative Splicing Pathway
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| AGO3 | Argonaute RISC Catalytic Component 3 |
| ALDH3B1 | Medium-Chain Fatty Aldehyde Dehydrogenase |
| ALS | Amyotrophic Lateral Sclerosis |
| ALYREF | Aly/REF export factor |
| ATG | Autophagy-related gene |
| ATX | Ataxin |
| ATXN2 | Ataxin-2 |
| ATXN2L | Ataxin-2-like |
| AU-rich | Adenosin-Uridine rich |
| BCA | Bicinchoninic Acid |
| bp | base pairs |
| CAG | Cytosine–Adenine–Guanine trinucleotide repeat |
| CamK2a | Calcium/calmodulin-dependent protein kinase II alpha |
| cKO | conditional Knock-Out |
| Cre | Cyclization recombination enzyme |
| DEAD | Asp-Glu-Ala-Asp (DEAD-box helicase family) |
| DIA | Data-independent acquisition |
| DNA | Deoxyribo-Nucleic Acid |
| DTA | Diphtheria toxin fragment A |
| DxxD | Aspartate – any amino acid – any amino acid - Apartate |
| EDC4 | Enhancer Of mRNA Decapping 4 |
| EGF | Epidermal Growth Factor |
| ER | Endoplasmic Reticulum |
| ERT2 | Tamoxifen-inducible estrogen receptor domain, improved version |
| ES | Embryonic Stem Cells |
| FDR | False Discovery Rate |
| FEBS | Federation of European Biochemical Societies |
| FIJI | FIJI Is Just ImageJ |
| floxed | sequence flanked by two loxP sites |
| FMRP | Fragile X Mental Retardation Protein |
| FMR1 | Fragile X Messenger Ribonucleoprotein 1 |
| FXR2 | Fragile X Mental Retardation, Autosomal Homolog 2 |
| GO | Gene Ontology |
| G3BP2 | GTPase Activating Protein (SH3 Domain) Binding Protein 2 |
| hATXN2 | human Ataxin-2 |
| het | heterozygous |
| hom | homozygous |
| HSC | Hematopoietic Stem Cell |
| kb | kilo-bases |
| KEGG | Kyoto Encyclopedia of Genes and Genomes |
| KO | Knock-Out |
| LARP7 | La Ribonucleoprotein 7, Transcription Regulator, binds U6 snRNA |
| LC | Liquid Chromatography |
| LED | Light Emitting Diode |
| LoxP | Locus of X-over (crossing-over) in bacteriophage P1 |
| Lsm | Like-Sm domain |
| LsmAD | Like-Sm associated domain |
| LSM3 | LSM3 Homolog, U6 Small Nuclear RNA Associated |
| MAF1 | MAF1 Homolog, Negative Regulator Of RNA Polymerase III |
| MPL | Myelo-Proliferative Leukaemia Protein |
| mRNA | messenger Ribo-Nucleic Acid |
| MRPL14 | Large Ribosomal Subunit Protein UL14m |
| MS | Mass Spectrometry |
| mTOR | mechanistic Target of Rapamycin |
| mTORC1 | mechanistic Target of Rapamycin-Complex associated protein 1 |
| m5C | 5-methyl-Cytosine |
| NAA38 | N-Alpha-Acetyltransferase 38, NatC Auxiliary Subunit |
| NGS | Normal goat serum |
| NSUN2 | NOP2/Sun RNA Methyltransferase 2 |
| NUFIP2 | Nuclear Fragile X Mental Retardation Protein Interacting Protein 2 |
| oligo(U) | several (Uridine bases) |
| OR | Odds Ratio |
| PABP | Poly(A)-Binding Protein |
| PAM2 | Poly(A)-Binding protein association Motif type 2 |
| PASEF | Parallel Accumulation Serial Fragmentation |
| Pat1 | yeast factor for protection of mRNA 3'-UTRs from trimming |
| P-bodies | processing bodies in the cytosol, where RNA is degraded |
| Pbp1 | Poly(A)-binding protein 1 in yeast |
| PBS | Phosphate-Buffered Saline |
| PCR | Polymerase Chain Reaction |
| Poly(A) | many (Adenine bases) |
| polyQ | many Glutamine amino acids |
| PRM | Proline-rich motif |
| REEP3 | Receptor Expression-Enhancing Protein 3 |
| RNA | Ribo-Nucleic Acid |
| RNP | Ribo-Nucleoprotein |
| RoxP | loxP-analogous site, recognized by phage integrase Dre |
| RPS3 | Small Ribosomal Subunit Protein US3 |
| RRM | RNA Recognition Motif |
| rRNA | ribosomal Ribo-Nucleic Acid |
| RT | Reverse Transcription |
| SCA2 | Spinocerebellar Ataxia type 2 |
| SD | Standard Deviation |
| SEM | Standard Error of the Mean |
| SG | Stress Granule |
| siRNA | Small Interfering RNA |
| SN | Substantia Nigra |
| SNP | Single Nucleotide Polymorphism |
| snRNA | small nuclear Ribo-Nucleic Acid |
| snRNP | small nuclear Ribo-Nucleic-Acid binding protein |
| SR | Serine/Arginine-rich protein, family of splicing factors |
| SRSF11 | Serine And Arginine Rich Splicing Factor 11 |
| SYNE2 | Spectrin Repeat Containing Nuclear Envelope Protein 2 |
| TAM | Tamoxifen |
| TDP-43 | TAR DNA-Binding Protein-43 |
| Tg | Transgenic |
| tRNA | transfer Ribo-Nucleic Acid |
| UPR | Unfolded Protein Response |
| UTR | un-translated region of mRNA |
| U2AF65 | U2 Small Nuclear RNA Auxiliary Factor 2 |
| WB | Western Blot |
| WT | Wild-Type |
| YBX1 | Y-Box-Binding Protein 1, CCAAT-Binding Transcription Factor I |
| ZFE | Zentrale Forschungseinrichtung (Central Animal Facility) |
References
- Achsel, T., H. Stark, and R. Luhrmann, The Sm domain is an ancient RNA-binding motif with oligo(U) specificity. Proc Natl Acad Sci U S A, 2001. 98(7): p. 3685-9. [CrossRef]
- Tharun, S., et al., Yeast Sm-like proteins function in mRNA decapping and decay. Nature, 2000. 404(6777): p. 515-8. [CrossRef]
- Mura, C., et al., Archaeal and eukaryotic homologs of Hfq: A structural and evolutionary perspective on Sm function. RNA Biol, 2013. 10(4): p. 636-51.
- Swisher, K.D. and R. Parker, Localization to, and effects of Pbp1, Pbp4, Lsm12, Dhh1, and Pab1 on stress granules in Saccharomyces cerevisiae. PLoS One, 2010. 5(4): p. e10006. [CrossRef]
- Seidel, G., et al., Quantitative Global Proteomics of Yeast PBP1 Deletion Mutants and Their Stress Responses Identifies Glucose Metabolism, Mitochondrial, and Stress Granule Changes. J Proteome Res, 2017. 16(2): p. 504-515. [CrossRef]
- Yang, Y.S., et al., Yeast Ataxin-2 Forms an Intracellular Condensate Required for the Inhibition of TORC1 Signaling during Respiratory Growth. Cell, 2019. 177(3): p. 697-710 e17. [CrossRef]
- Kato, M., et al., Redox State Controls Phase Separation of the Yeast Ataxin-2 Protein via Reversible Oxidation of Its Methionine-Rich Low-Complexity Domain. Cell, 2019. 177(3): p. 711-721 e8. [CrossRef]
- Kiehl, T.R., H. Shibata, and S.M. Pulst, The ortholog of human ataxin-2 is essential for early embryonic patterning in C. elegans. J Mol Neurosci, 2000. 15(3): p. 231-41. [CrossRef]
- Ciosk, R., M. DePalma, and J.R. Priess, ATX-2, the C. elegans ortholog of ataxin 2, functions in translational regulation in the germline. Development, 2004. 131(19): p. 4831-41. [CrossRef]
- Bar, D.Z., et al., Cell size and fat content of dietary-restricted Caenorhabditis elegans are regulated by ATX-2, an mTOR repressor. Proc Natl Acad Sci U S A, 2016. 113(32): p. E4620-9. [CrossRef]
- Stubenvoll, M.D., et al., ATX-2, the C. elegans Ortholog of Human Ataxin-2, Regulates Centrosome Size and Microtubule Dynamics. PLoS Genet, 2016. 12(9): p. e1006370. [CrossRef]
- Del Castillo, U., et al., Conserved role for Ataxin-2 in mediating endoplasmic reticulum dynamics. Traffic, 2019. 20(6): p. 436-447. [CrossRef]
- Beath, E.A., et al., Katanin, kinesin-13, and ataxin-2 inhibit premature interaction between maternal and paternal genomes in C. elegans zygotes. Elife, 2024. 13.
- Satterfield, T.F., S.M. Jackson, and L.J. Pallanck, A Drosophila homolog of the polyglutamine disease gene SCA2 is a dosage-sensitive regulator of actin filament formation. Genetics, 2002. 162(4): p. 1687-702. [CrossRef]
- Satterfield, T.F. and L.J. Pallanck, Ataxin-2 and its Drosophila homolog, ATX2, physically assemble with polyribosomes. Hum Mol Genet, 2006. 15(16): p. 2523-32. [CrossRef]
- Al-Ramahi, I., et al., dAtaxin-2 mediates expanded Ataxin-1-induced neurodegeneration in a Drosophila model of SCA1. PLoS Genet, 2007. 3(12): p. e234. [CrossRef]
- McCann, C., et al., The Ataxin-2 protein is required for microRNA function and synapse-specific long-term olfactory habituation. Proc Natl Acad Sci U S A, 2011. 108(36): p. E655-62. [CrossRef]
- Lim, C. and R. Allada, ATAXIN-2 activates PERIOD translation to sustain circadian rhythms in Drosophila. Science, 2013. 340(6134): p. 875-9. [CrossRef]
- Zhang, Y., et al., A role for Drosophila ATX2 in activation of PER translation and circadian behavior. Science, 2013. 340(6134): p. 879-82. [CrossRef]
- Sudhakaran, I.P., et al., FMRP and Ataxin-2 function together in long-term olfactory habituation and neuronal translational control. Proc Natl Acad Sci U S A, 2014. 111(1): p. E99-E108. [CrossRef]
- Vianna, M.C., et al., Drosophila ataxin-2 gene encodes two differentially expressed isoforms and its function in larval fat body is crucial for development of peripheral tissues. FEBS Open Bio, 2016. 6(11): p. 1040-1053. [CrossRef]
- Lee, J., et al., LSM12 and ME31B/DDX6 Define Distinct Modes of Posttranscriptional Regulation by ATAXIN-2 Protein Complex in Drosophila Circadian Pacemaker Neurons. Mol Cell, 2017. 66(1): p. 129-140 e7. [CrossRef]
- Bakthavachalu, B., et al., RNP-Granule Assembly via Ataxin-2 Disordered Domains Is Required for Long-Term Memory and Neurodegeneration. Neuron, 2018. 98(4): p. 754-766 e4. [CrossRef]
- Cha, I.J., et al., Ataxin-2 Dysregulation Triggers a Compensatory Fragile X Mental Retardation Protein Decrease in Drosophila C4da Neurons. Mol Cells, 2020. 43(10): p. 870-879. [CrossRef]
- Singh, A., et al., Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensation. Elife, 2021. 10. [CrossRef]
- Del Castillo, U., et al., Ataxin-2 is essential for cytoskeletal dynamics and neurodevelopment in Drosophila. iScience, 2022. 25(1): p. 103536. [CrossRef]
- Corgiat, E.B., et al., The Nab2 RNA-binding protein patterns dendritic and axonal projections through a planar cell polarity-sensitive mechanism. G3 (Bethesda), 2022. 12(6). [CrossRef]
- Petrauskas, A., et al., Structured and disordered regions of Ataxin-2 contribute differently to the specificity and efficiency of mRNP granule formation. PLoS Genet, 2024. 20(5): p. e1011251. [CrossRef]
- Auburger, G., et al., Efficient Prevention of Neurodegenerative Diseases by Depletion of Starvation Response Factor Ataxin-2. Trends Neurosci, 2017. 40(8): p. 507-516. [CrossRef]
- Jimenez-Lopez, D. and P. Guzman, Insights into the evolution and domain structure of Ataxin-2 proteins across eukaryotes. BMC Res Notes, 2014. 7: p. 453. [CrossRef]
- Pulst, S.M., et al., Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet, 1996. 14(3): p. 269-76. [CrossRef]
- Sanpei, K., et al., Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet, 1996. 14(3): p. 277-84. [CrossRef]
- Imbert, G., et al., Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat Genet, 1996. 14(3): p. 285-91. [CrossRef]
- Velazquez-Perez, L., et al., Saccade velocity is controlled by polyglutamine size in spinocerebellar ataxia 2. Ann Neurol, 2004. 56(3): p. 444-7. [CrossRef]
- Rub, U., et al., Spinocerebellar ataxias types 2 and 3: degeneration of the pre-cerebellar nuclei isolates the three phylogenetically defined regions of the cerebellum. J Neural Transm (Vienna), 2005. 112(11): p. 1523-45. [CrossRef]
- Gierga, K., et al., Involvement of the cranial nerves and their nuclei in spinocerebellar ataxia type 2 (SCA2). Acta Neuropathol, 2005. 109(6): p. 617-31. [CrossRef]
- Ralser, M., et al., Ataxin-2 and huntingtin interact with endophilin-A complexes to function in plastin-associated pathways. Hum Mol Genet, 2005. 14(19): p. 2893-909. [CrossRef]
- Tuin, I., et al., Stages of sleep pathology in spinocerebellar ataxia type 2 (SCA2). Neurology, 2006. 67(11): p. 1966-72. [CrossRef]
- Lastres-Becker, I., et al., Insulin receptor and lipid metabolism pathology in ataxin-2 knock-out mice. Hum Mol Genet, 2008. 17(10): p. 1465-81. [CrossRef]
- Lastres-Becker, I., U. Rub, and G. Auburger, Spinocerebellar ataxia 2 (SCA2). Cerebellum, 2008. 7(2): p. 115-24.
- Nonis, D., et al., Ataxin-2 associates with the endocytosis complex and affects EGF receptor trafficking. Cell Signal, 2008. 20(10): p. 1725-39. [CrossRef]
- Rub, U., et al., Thalamic involvement in a spinocerebellar ataxia type 2 (SCA2) and a spinocerebellar ataxia type 3 (SCA3) patient, and its clinical relevance. Brain, 2003. 126(Pt 10): p. 2257-72. [CrossRef]
- van de Loo, S., et al., Ataxin-2 associates with rough endoplasmic reticulum. Exp Neurol, 2009. 215(1): p. 110-8.
- Almaguer-Mederos, L.E., et al., Estimation of the age at onset in spinocerebellar ataxia type 2 Cuban patients by survival analysis. Clin Genet, 2010. 78(2): p. 169-74. [CrossRef]
- Auburger, G.W., Spinocerebellar ataxia type 2. Handb Clin Neurol, 2012. 103: p. 423-36.
- Rub, U., et al., Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7. Prog Neurobiol, 2013. 104: p. 38-66. [CrossRef]
- Schols, L., et al., No parkinsonism in SCA2 and SCA3 despite severe neurodegeneration of the dopaminergic substantia nigra. Brain, 2015. 138(Pt 11): p. 3316-26. [CrossRef]
- Meierhofer, D., et al., Ataxin-2 (Atxn2)-Knock-Out Mice Show Branched Chain Amino Acids and Fatty Acids Pathway Alterations. Mol Cell Proteomics, 2016. 15(5): p. 1728-39. [CrossRef]
- Halbach, M.V., et al., Atxn2 Knockout and CAG42-Knock-in Cerebellum Shows Similarly Dysregulated Expression in Calcium Homeostasis Pathway. Cerebellum, 2017. 16(1): p. 68-81. [CrossRef]
- Lastres-Becker, I., et al., Mammalian ataxin-2 modulates translation control at the pre-initiation complex via PI3K/mTOR and is induced by starvation. Biochim Biophys Acta, 2016. 1862(9): p. 1558-69. [CrossRef]
- Seidel, K., et al., On the distribution of intranuclear and cytoplasmic aggregates in the brainstem of patients with spinocerebellar ataxia type 2 and 3. Brain Pathol, 2017. 27(3): p. 345-355. [CrossRef]
- Sen, N.E., et al., Generation of an Atxn2-CAG100 knock-in mouse reveals N-acetylaspartate production deficit due to early Nat8l dysregulation. Neurobiol Dis, 2019. 132: p. 104559. [CrossRef]
- Xu, F., et al., Ataxin2 functions via CrebA to mediate Huntingtin toxicity in circadian clock neurons. PLoS Genet, 2019. 15(10): p. e1008356. [CrossRef]
- Elden, A.C., et al., Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature, 2010. 466(7310): p. 1069-75. [CrossRef]
- Becker, L.A., et al., Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. Nature, 2017. 544(7650): p. 367-371. [CrossRef]
- Gispert, S., et al., The modulation of Amyotrophic Lateral Sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effect. Neurobiol Dis, 2012. 45(1): p. 356-61. [CrossRef]
- Lahut, S., et al., ATXN2 and its neighbouring gene SH2B3 are associated with increased ALS risk in the Turkish population. PLoS One, 2012. 7(8): p. e42956. [CrossRef]
- Lee, T., et al., Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients. Hum Mol Genet, 2011. 20(9): p. 1697-700. [CrossRef]
- Ralser, M., et al., An integrative approach to gain insights into the cellular function of human ataxin-2. J Mol Biol, 2005. 346(1): p. 203-14. [CrossRef]
- Nonhoff, U., et al., Ataxin-2 interacts with the DEAD/H-box RNA helicase DDX6 and interferes with P-bodies and stress granules. Mol Biol Cell, 2007. 18(4): p. 1385-96. [CrossRef]
- Damrath, E., et al., ATXN2-CAG42 sequesters PABPC1 into insolubility and induces FBXW8 in cerebellum of old ataxic knock-in mice. PLoS Genet, 2012. 8(8): p. e1002920. [CrossRef]
- Kaehler, C., et al., Ataxin-2-like is a regulator of stress granules and processing bodies. PLoS One, 2012. 7(11): p. e50134. [CrossRef]
- Yokoshi, M., et al., Direct binding of Ataxin-2 to distinct elements in 3' UTRs promotes mRNA stability and protein expression. Mol Cell, 2014. 55(2): p. 186-98. [CrossRef]
- Fittschen, M., et al., Genetic ablation of ataxin-2 increases several global translation factors in their transcript abundance but decreases translation rate. Neurogenetics, 2015. 16(3): p. 181-92. [CrossRef]
- Inagaki, H., et al., Direct evidence that Ataxin-2 is a translational activator mediating cytoplasmic polyadenylation. J Biol Chem, 2020. 295(47): p. 15810-15825. [CrossRef]
- Canet-Pons, J., et al., Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppression. Neurobiol Dis, 2021. 152: p. 105289. [CrossRef]
- Boeynaems, S., et al., Poly(A)-binding protein is an ataxin-2 chaperone that regulates biomolecular condensates. Mol Cell, 2023. 83(12): p. 2020-2034 e6. [CrossRef]
- Zhuang, Y., et al., Circadian clocks are modulated by compartmentalized oscillating translation. Cell, 2023. 186(15): p. 3245-3260 e23. [CrossRef]
- Wang, J.Y., et al., PolyQ-expanded ataxin-2 aggregation impairs cellular processing-body homeostasis via sequestering the RNA helicase DDX6. J Biol Chem, 2024. 300(7): p. 107413. [CrossRef]
- Zhang, S., et al., The LSmAD Domain of Ataxin-2 Modulates the Structure and RNA Binding of Its Preceding LSm Domain. Cells, 2025. 14(5). [CrossRef]
- Drost, J., et al., Ataxin-2 modulates the levels of Grb2 and SRC but not ras signaling. J Mol Neurosci, 2013. 51(1): p. 68-81. [CrossRef]
- Meunier, C., et al., Cloning and characterization of a family of proteins associated with Mpl. J Biol Chem, 2002. 277(11): p. 9139-47. [CrossRef]
- Coller, J. and R. Parker, General translational repression by activators of mRNA decapping. Cell, 2005. 122(6): p. 875-86. [CrossRef]
- Lobel, J.H. and J.D. Gross, Pdc2/Pat1 increases the range of decay factors and RNA bound by the Lsm1-7 complex. RNA, 2020. 26(10): p. 1380-1388. [CrossRef]
- Hurst, Z., et al., A distinct P-body-like granule is induced in response to the disruption of microtubule integrity in Saccharomyces cerevisiae. Genetics, 2022. 222(1). [CrossRef]
- Vijjamarri, A.K., et al., mRNA decapping activators Pat1 and Dhh1 regulate transcript abundance and translation to tune cellular responses to nutrient availability. Nucleic Acids Res, 2023. 51(17): p. 9314-9336. [CrossRef]
- Bahassou-Benamri, R., et al., Subcellular localization and interaction network of the mRNA decay activator Pat1 upon UV stress. Yeast, 2013. 30(9): p. 353-63. [CrossRef]
- Vindry, C., et al., Dual RNA Processing Roles of Pat1b via Cytoplasmic Lsm1-7 and Nuclear Lsm2-8 Complexes. Cell Rep, 2017. 20(5): p. 1187-1200.
- Vindry, C., D. Weil, and N. Standart, Pat1 RNA-binding proteins: Multitasking shuttling proteins. Wiley Interdiscip Rev RNA, 2019. 10(6): p. e1557. [CrossRef]
- Pradhan, S.J., et al., The conserved P body component HPat/Pat1 negatively regulates synaptic terminal growth at the larval Drosophila neuromuscular junction. J Cell Sci, 2012. 125(Pt 24): p. 6105-16. [CrossRef]
- Kaehler, C., et al., PRMT1-mediated arginine methylation controls ATXN2L localization. Exp Cell Res, 2015. 334(1): p. 114-25. [CrossRef]
- Key, J., et al., ATXN2L primarily interacts with NUFIP2, the absence of ATXN2L results in NUFIP2 depletion, and the ATXN2-polyQ expansion triggers NUFIP2 accumulation. Neurobiol Dis, 2025. 209: p. 106903. [CrossRef]
- Key, J., et al., Mid-Gestation lethality of Atxn2l-Ablated Mice. Int J Mol Sci, 2020. 21(14). [CrossRef]
- Truett, G.E., et al., Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Biotechniques, 2000. 29(1): p. 52, 54. [CrossRef]
- Schindelin, J., et al., Fiji: an open-source platform for biological-image analysis. Nat Methods, 2012. 9(7): p. 676-82. [CrossRef]
- Martens, L., et al., PRIDE: the proteomics identifications database. Proteomics, 2005. 5(13): p. 3537-45.
- Szklarczyk, D., et al., The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res, 2023. 51(D1): p. D638-D646. [CrossRef]
- Zhang, S., et al., Beyond regulation of pol III: Role of MAF1 in growth, metabolism, aging and cancer. Biochim Biophys Acta Gene Regul Mech, 2018. 1861(4): p. 338-343. [CrossRef]
- Schlaitz, A.L., et al., REEP3/4 ensure endoplasmic reticulum clearance from metaphase chromatin and proper nuclear envelope architecture. Dev Cell, 2013. 26(3): p. 315-23. [CrossRef]
- Burke, B., PREEParing for mitosis. Dev Cell, 2013. 26(3): p. 221-2. [CrossRef]
- Urlaub, H., et al., Sm protein-Sm site RNA interactions within the inner ring of the spliceosomal snRNP core structure. EMBO J, 2001. 20(1-2): p. 187-96. [CrossRef]
- Decker, C.J. and R. Parker, P-bodies and stress granules: possible roles in the control of translation and mRNA degradation. Cold Spring Harb Perspect Biol, 2012. 4(9): p. a012286. [CrossRef]
- Hayashi, S. and A.P. McMahon, Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev Biol, 2002. 244(2): p. 305-18. [CrossRef]
- Eckardt, D., et al., Spontaneous ectopic recombination in cell-type-specific Cre mice removes loxP-flanked marker cassettes in vivo. Genesis, 2004. 38(4): p. 159-65.
- Chakravarthy, S., et al., Cre-dependent expression of multiple transgenes in isolated neurons of the adult forebrain. PLoS One, 2008. 3(8): p. e3059. [CrossRef]
- Senserrich, J., et al., Analysis of Runx1 Using Induced Gene Ablation Reveals Its Essential Role in Pre-liver HSC Development and Limitations of an In Vivo Approach. Stem Cell Reports, 2018. 11(3): p. 784-794. [CrossRef]
- Crawley, J.N., Behavioral phenotyping strategies for mutant mice. Neuron, 2008. 57(6): p. 809-18. [CrossRef]
- Kwon, D.Y., et al., Neuronal Yin Yang1 in the prefrontal cortex regulates transcriptional and behavioral responses to chronic stress in mice. Nat Commun, 2022. 13(1): p. 55. [CrossRef]
- Mastwal, S., et al., Adolescent neurostimulation of dopamine circuit reverses genetic deficits in frontal cortex function. Elife, 2023. 12.
- Bish, R., et al., Comprehensive Protein Interactome Analysis of a Key RNA Helicase: Detection of Novel Stress Granule Proteins. Biomolecules, 2015. 5(3): p. 1441-66. [CrossRef]
- Shah, S., et al., FMRP Control of Ribosome Translocation Promotes Chromatin Modifications and Alternative Splicing of Neuronal Genes Linked to Autism. Cell Rep, 2020. 30(13): p. 4459-4472 e6. [CrossRef]
- Brown, A.L., et al., TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A. Nature, 2022. 603(7899): p. 131-137. [CrossRef]
- Takayama, K.I., et al., Cooperative nuclear action of RNA-binding proteins PSF and G3BP2 to sustain neuronal cell viability is decreased in aging and dementia. Aging Cell, 2024. 23(12): p. e14316. [CrossRef]
- Goebbels, S., et al., Genetic targeting of principal neurons in neocortex and hippocampus of NEX-Cre mice. Genesis, 2006. 44(12): p. 611-21. [CrossRef]
- Yang, X., et al., 5-methylcytosine promotes mRNA export - NSUN2 as the methyltransferase and ALYREF as an m(5)C reader. Cell Res, 2017. 27(5): p. 606-625. [CrossRef]
- Chen, X., et al., 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs. Nat Cell Biol, 2019. 21(8): p. 978-990. [CrossRef]
- Chaudhary, N., C. McMahon, and G. Blobel, Primary structure of a human arginine-rich nuclear protein that colocalizes with spliceosome components. Proc Natl Acad Sci U S A, 1991. 88(18): p. 8189-93. [CrossRef]
- Twyffels, L., C. Gueydan, and V. Kruys, Shuttling SR proteins: more than splicing factors. FEBS J, 2011. 278(18): p. 3246-55. [CrossRef]
- Zhang, W.J. and J.Y. Wu, Functional properties of p54, a novel SR protein active in constitutive and alternative splicing. Mol Cell Biol, 1996. 16(10): p. 5400-8. [CrossRef]
- Kennedy, C.F., A. Kramer, and S.M. Berget, A role for SRp54 during intron bridging of small introns with pyrimidine tracts upstream of the branch point. Mol Cell Biol, 1998. 18(9): p. 5425-34. [CrossRef]
- Gehring, N.H. and J.Y. Roignant, Anything but Ordinary - Emerging Splicing Mechanisms in Eukaryotic Gene Regulation. Trends Genet, 2021. 37(4): p. 355-372. [CrossRef]





| Observed / Expected Number of Live Born Mice with Indicated Genotype | ||||
| +/+ | +/- | -/- | Number of offspring | |
| Live born female | 33/27 | 39/54 | 0/27 | 72/108 |
| Live born male | 20/27 | 26/54 | 0/27 | 46/108 |
| Live born total | 53/54 | 65/108 | 0/54 | 118/216 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).